Skip to main content
main-content

09.09.2015 | Onkologie | Onlineartikel

Metastatic NSCLC: 
new drugs and updates on well-known agents

Tumours with squamous histology account for 20 % to 30 % of cases of non–small-cell lung cancer (NSCLC). Despite this substantial proportion, only limited progress has been made in the treatment of advanced squamous-cell carcinoma (SCC) compared to non-squamous NSCLC, and thus SCC of the lung is a disease with a high unmet medical need.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten